Life, you make us stronger at our weakest.
A whole-person approach to cancer care
Call for more information.
Call: 503-215-6014Providence Cancer Institute of Oregon
503-215-6014
Providence Cancer Institute of Oregon
At Providence, we see more than a cancer diagnosis, we see the journey you’re on and a way forward together. We surround you with the brightest cancer experts and compassionate cancer navigators who provide individual support and help coordinate every step of your care. Our goal is to make you well again.
Expert Cancer Care
Cancer Specialists
We offer rapid access to cancer specialists throughout Oregon. Our clinics provide expertise in cancer prevention, diagnosis and treatment.
Our advanced treatment options include gene sequencing, immunotherapy, minimally invasive surgery and MRI-guided radiation therapy.
Our scientists and clinicians work together to improve the standard of care through the integration of clinical trials into medical practice.
Patient and provider resources
Patient resources
-
Supporting our patients
We provide an abundance of support resources to our patients. This extra dimension of care supports patients and their families mentally, physically and emotionally. - Screening and prevention
Regular cancer screening can prevent some cancers, and catch others early, when they are easier to treat. - Advanced treatment options
Our experts integrate the most promising and effective treatments to personalize your care.
Referring physicians
We make every effort to partner with our referring providers and provide excellent care of our patients. Learn more about provider resources.
See Our Latest News
5/23/2022
Florida woman with metastatic pancreatic cancer participates in groundbreaking clinical trial of adoptive cellular therapy only available at Providence Cancer Institute.
5/19/2022
May 20 is International Clinical Trials Day. Clinical trials are evidence-based studies in people that result in the biggest breakthroughs in cancer research.
5/11/2022
Two new clinical trials available at Providence will evaluate whether a combination of medications are effective and safe therapies for people with metastatic melanoma and metastatic uveal melanoma.
4/28/2022
Researchers of the Earle A. Chiles Research Institute, a division of Providence Cancer Institute of Oregon, will present their latest cancer immunotherapy data at Immunology2022 in May.